The molecular genetics of breast cancer: The contribution of comparative genomic hybridization


Autoria(s): Reis-Filho, Jorge S.; Simpson, Peter T.; Gale, Theodora; Lakhani, Sunil R.
Data(s)

25/11/2005

Resumo

Comparative genomic hybridization (CGH) has been the technique of choice over the last 10 years for mapping DNA copy number changes in human tumors. Here we review the literature to demonstrate how CGH has contributed to the comprehension of molecular aspects of breast tumorigenesis. At least two distinct molecular pathways of breast cancer have been characterized that show a strong correlation with histological grade. It seems that grade I invasive ductal carcinomas (IDCs) arise from well-differentiated ductal carcinoma in situ (DCIS), whereas grade III IDCs come from poorly differentiated DCIS. In addition, dedifferentiation from a low- to a high-grade breast cancer has proven an unlikely phenomenon. CGH has been instrumental in dissecting distinct molecular pathways toward breast malignancy and in establishing a direct relationship between genotype and clinical pathological features. (C) 2005 Elsevier GrnbH. All rights reserved.

Identificador

http://espace.library.uq.edu.au/view/UQ:74875

Idioma(s)

eng

Publicador

Elsevier

Palavras-Chave #Pathology #Breast cancer #Comparative genomic hybridization #DNA copy number changes #Loss of heterozygosity #Carcinoma in-situ #Invasive ductal carcinoma #Atypical lobular hyperplasia #Standard reference intervals #Columnar cell lesions #Copy number changes #E-cadherin #Chromosomal imbalances #Allelic imbalance #C1 #321020 Pathology #730108 Cancer and related disorders #1103 Clinical Sciences #1112 Oncology and Carcinogenesis
Tipo

Journal Article